Roles of the ACE/Ang II/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis
Author:
- 21 June 2022
- journal article
- other
- Published by Taylor & Francis in Tissue Barriers
- Vol. 11 (2) , 192-209
Abstract
This paper shows how SARS-CoV-2 alters tight junctions (TJs) in human organs. The effect of SARS-CoV-2 on the ACE/Ang II/AT1R pathway and immune cells culminates in the release of numerous pro-inflammatory mediators, leading to the presence of certain symptoms in COVID-19, such as acute lung injury (ALI), pulmonary hypertension, and pulmonary fibrosis. Furthermore, the cytokines released alter different TJs components. The study shows how the irregular release of pro-inflammatory cytokines leads to claudin disruption in various tissues of the body, resulting in different symptoms, such as alveolar fibrosis, pulmonary edema, conjunctivitis, altered fertility in males, gastrointestinal symptoms, Covid toes, and others. SARS-CoV-2 also alters occludin expression in the endothelial and blood-testis barriers (BTB) resulting in edema and altered fertility. Viral disruption of JAM-A leads to activation of the RhoA GTPase, which leads to ALI. Taken together, these results define ACE/Ang II/AT1R pathway receptors and tight junctional components as potential therapeutic targets in COVID-19.Keywords
Funding Information
- reported that there is no funding associated with the work featured in this article
This publication has 148 references indexed in Scilit:
- JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier functionMolecular Biology of the Cell, 2013
- Influenza Infects Lung Microvascular Endothelium Leading to Microvascular Leak: Role of Apoptosis and Claudin-5PLOS ONE, 2012
- Occludin: One Protein, Many FormsMolecular and Cellular Biology, 2012
- Claudins in lung diseasesRespiratory Research, 2011
- Prostaglandin E2 Induces Matrix Metalloproteinase 9 Expression in Dendritic Cells through Two Independent Signaling Pathways Leading to Activator Protein 1 (AP-1) ActivationJournal of Biological Chemistry, 2011
- Regulation of a novel angiotensin II precursor, proangiotensin-12, in the tissues by blockade of the renin–angiotensin systemHypertension Research, 2011
- ADAM-17: the enzyme that does it allCritical Reviews in Biochemistry and Molecular Biology, 2010
- Cytokine regulation of tight junctionsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- The claudinsGenome Biology, 2009
- Claudin-1, −2, −3, −4, −5, and −7 in Usual Interstitial Pneumonia and SarcoidosisJournal of Histochemistry & Cytochemistry, 2008